AUH.F EGF THERAMED HEALTH CORP.

Healthcare Health Care Technology Frankfurt Exchange
0.0005 EUR
Close of Nov 11, 2026
0.0005 0.0500
Market cap
EUR 5.81K
P/E
-
P/B
1.37x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Mar 2026.

Is AUH.F undervalued?

Graham number

The Graham number of EGF THERAMED HEALTH CORP. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

EGF THERAMED HEALTH CORP. fundamental analysis

No fundamental analysis for EGF THERAMED HEALTH CORP. yet.

EGF THERAMED HEALTH CORP. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About EGF THERAMED HEALTH CORP.

EGF Theramed Health Corp. engages in the development of psychedelic drugs for the treatment of mental health problems in Canada. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression, as well as natural health and wellness products. The company also explores other medical areas, including weight loss, skin care, and heart disease. EGF Theramed Health Corp. is headquartered in Vancouver, Canada.

Full company profile